Skip to main content
All lobbying filings

TIBER CREEK GROUP

TIBER CREEK GROUP filed a Q2 report for ACADIA PHARMACEUTICALS, INC. on July 19, 2026, reporting $80,000 in lobbying income.

Lobbying for ACADIA PHARMACEUTICALS, INC. · Biopharmaceutical company.

All filings by TIBER CREEK GROUP · Everything ACADIA PHARMACEUTICALS, INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 19, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Issues related to drug pricing; Issues related to the Inflation Reduction Act (PL 117-169).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem